12 /100
LOW RISK
Score updated Jul 14, 2026

BNT — Brookfield Wealth Solutions Ltd. Dilution Risk Tracker

Track BNT dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track BNT — Get alerts when the score changes →

As of July 14, 2026, Brookfield Wealth Solutions Ltd. (BNT) has a DilutionWatch DilutionScore of 12/100, rated LOW dilution risk. Brookfield Wealth Solutions Ltd. has a market capitalization of $12.51B, 15.31M shares outstanding, 2 institutional holders tracked. Key dilution vectors include approximately 999 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
26
💰 Cash Runway
0
📊 Float Risk
7
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for BNT.
🔔 Track BNT — Get forecast alerts →

💹 Market Data

Market Cap$12.51B
Shares Outstanding15.31M
FloatN/A
Cash$13.49B
Debt$8.72B
Short InterestN/A

🏛 Institutional Holdings

2 institutional holders · 6.1K shares
#1 BARCLAYS PLC 5.8K shares
#2 DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main 371 shares

📉 Short Interest

Short Interest253.4K
Days to Cover7.6
% of FloatN/A
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Jul 07, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for BNT Shareholders

Brookfield Wealth Solutions Ltd. (BNT) has a DilutionScore of 12/100, rated Low dilution risk. At this score level, DilutionWatch's real-time EDGAR monitoring shows limited near-term dilution signals. This does not mean zero dilution risk — shelf registrations can be filed and activated quickly — but the current filing profile shows no major outstanding dilution programs. Score as of July 14, 2026.

DilutionWatch's EDGAR monitoring for BNT shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for BNT in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for BNT alongside comparable low-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track BNT Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking BNT — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for BNT
📊 BNT FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 BNT Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.